Lurasidone - Sumitomo Pharma (Suzhou) Co., Ltd. | Clinical Trial Radar

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Let's discuss and explore clinical trials with Sumitomo Pharma as a lead sponsor or collaborator. I can help you find nearby clinical trials and understand health conditions and treatments.

Let's discuss and explore clinical trials with Sumitomo Pharma as a lead sponsor or collaborator.

I can help you find nearby clinical trials and understand health conditions and treatments.

Study Title	Status
The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine NCT05213143	Terminated
The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia NCT05011669	Completed
The Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia Patients NCT04432688	Completed
A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression NCT04383691	Terminated
Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects NCT02174523	CompletedResults Posted
A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects NCT02174510	CompletedResults Posted
A Clinical Trial of Lurasidone in Treatment of Schizophrenia NCT02002832	CompletedResults Posted